00:00 / 00:00
Fibrocystic breast changes
Paget disease of the breast
Intrauterine growth restriction
Pelvic inflammatory disease
Gestational trophoblastic disease
Germ cell ovarian tumor
Polycystic ovary syndrome
Premature ovarian failure
Sex cord-gonadal stromal tumor
Surface epithelial-stromal tumor
Congenital cytomegalovirus (NORD)
Congenital rubella syndrome
Neonatal herpes simplex
Preeclampsia & eclampsia
Female sexual interest and arousal disorder
Genito-pelvic pain and penetration disorder
Fetal alcohol syndrome
Fetal hydantoin syndrome
Androgen insensitivity syndrome
Hypospadias and epispadias
Benign prostatic hyperplasia
Male hypoactive sexual desire disorder
Amenorrhea: Pathology review
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Cervical cancer: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Disorders of sex chromosomes: Pathology review
Disorders of sexual development and sex hormones: Pathology review
HIV and AIDS: Pathology review
Ovarian cysts and tumors: Pathology review
Penile conditions: Pathology review
Prostate disorders and cancer: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Sexually transmitted infections: Warts and ulcers: Pathology review
Testicular and scrotal conditions: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Vaginal and vulvar disorders: Pathology review
0 / 9 complete
Postpartum Hemorrhage - Uterine atony
postpartum hemorrhage p. NaN
Postpartum hemorrhage is a significant loss of blood after giving birth, and it’s the number one reason for maternal morbidity and maternal death around the world.
Specifically it’s defined as losing more than 500ml of blood after a vaginal delivery or more than 1000ml after a cesarean section delivery.
Of course, deliveries can be messy and it’s impossible to measure the precise amount of blood that’s lost, and there’s the possibility of internal bleeding.
So additional criteria to consider for postpartum hemorrhage include a decrease of 10% or more in hematocrit from baseline, as well as changes in the mother’s heart rate, blood pressure, and oxygen saturations —all of which suggest a significant blood loss.
Significant bleeding in the first 24 hours after delivery is called primary postpartum hemorrhage, and after that it’s called secondary, or late, postpartum hemorrhage.
The most common causes of postpartum hemorrhage can be lumped into four groups which can easily be remembered as the “4 Ts”: Tone, Trauma, Tissue, and Thrombin.
Tone refers to a lack of uterine tone, also known as uterine atony—basically a soft, spongy, boggy uterus, and this is the main cause of postpartum hemorrhage, generally resulting in a slow and steady loss of blood.
Now, the uterus is a muscular organ wrapped by three layers of smooth muscle called the myometrium, which contracts during labor to dilate and efface the cervix and ultimately push out the fetus and placenta.
After delivery, the myometrium continues to contract and this squeezes down on the placental arteries at the point where they are attached to the uterine wall, which clamps them shut, and therefore reduces uterine bleeding.
Postpartum hemorrhage is defined as blood loss of more than 500 mL for a vaginal delivery, or more than 1000 mL for cesarean delivery, within the first 24 hours following childbirth. Signs and symptoms may initially include: an increased heart rate, feeling faint upon standing, and an increased breath rate.
Risk factors for PPH include prolonged labor, a large baby, placenta complications, an infection, or underlying medical conditions. Treatment for PPH depends on the cause and can range from uterine massage to a blood transfusion. Prevention strategies include proper prenatal care, labor monitoring, and active management of the third stage of labor.
Latest on COVID-19
Nurse Practitioner (NP)
Physician Assistant (PA)
Create custom content
Raise the Line Podcast
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
Terms and Conditions
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.